Research ArticleArticle
Open Access
Serum Urate and Incidence of Kidney Disease Among Veterans with Gout
Eswar Krishnan, Kasem S. Akhras, Hari Sharma, Maryna Marynchenko, Eric Wu, Rima H. Tawk, Jinan Liu and Lizheng Shi
The Journal of Rheumatology May 2013, jrheum.121061; DOI: https://doi.org/10.3899/jrheum.121061
Eswar Krishnan
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Kasem S. Akhras
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Hari Sharma
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Maryna Marynchenko
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Eric Wu
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Rima H. Tawk
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Jinan Liu
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
Lizheng Shi
From Stanford University, Stanford, California; Takeda Pharmaceuticals International Inc., Deerfield, Illinois; Analysis Group Inc., Boston, Massachusetts; Tulane University, New Orleans, Louisiana; and Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Supported by Takeda Pharmaceuticals International Inc. Dr. Krishnan has served as a consultant to Takeda Pharmaceuticals Inc., URL Pharmaceuticals Inc., Metabolex Inc., and UCB Pharmaceuticals Inc., and has received grant support from URL, ARDEA biosciences, and Takeda. R.H. Tawk is supported by the University of Illinois at Chicago/Takeda Fellowship. E. Krishnan, MD, Stanford University; K.S. Akhras, PharmD, Takeda Pharmaceuticals International Inc.; H. Sharma, BS; M. Marynchenko, MBA; E. Wu, PhD, Analysis Group Inc.; R.H. Tawk, PhD, Takeda Pharmaceuticals International Inc.; J. Liu, PhD; L. Shi, PhD, Tulane University and Southeast Louisiana Veterans Health Care System. Address correspondence to M. Marynchenko, Analysis Group Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA. E-mail: mmarynchenko@analysisgroup.com. Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 20, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Serum Urate and Incidence of Kidney Disease Among Veterans with Gout
Eswar Krishnan, Kasem S. Akhras, Hari Sharma, Maryna Marynchenko, Eric Wu, Rima H. Tawk, Jinan Liu, Lizheng Shi
The Journal of Rheumatology May 2013, jrheum.121061; DOI: 10.3899/jrheum.121061